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Abstract
In contrast to peripheral macrophages, microglia in the central nervous system (CNS) 
exhibit a specific deactivated phenotype; however, it is not clear how this phenotype 
is maintained. Two alternative hypotheses were postulated recently: (a) microglia dif‐
fer from peripheral macrophages being derived from the yolk sac (YS), whereas pe‐
ripheral macrophages originate from bone marrow (BM); (b) microglia acquire a 
specific phenotype under the influence of the CNS microenvironment. We have pre‐
viously shown that microglia express miR‐124, which was also induced in BM‐derived 
macrophages co‐cultured with a neurons. We here investigated the possibility of 
horizontal transfer of the neuron‐specific microRNAs miR‐124 and miR‐9 from pri‐
mary neurons to microglia/macrophages. We found that after incubation with neu‐
ronal conditioned media (NCM), macrophages downregulated activation markers 
MHC class II and CD45. Neither cultured adult microglia nor YS‐ and BM‐derived 
macrophages demonstrated intrinsic levels of miR‐124 expression. However, after 
incubation with NCM, miR‐124 was induced in both YS‐ and BM‐derived mac‐
rophages. Biochemical analysis demonstrated that the NCM contained miR‐124 and 
miR‐9 in complex with small proteins, large high‐density lipoproteins (HDLs), and ex‐
osomes. MiR‐124 and miR‐9 were promptly released from neurons, and this process 
was inhibited by tetrodotoxin, indicating an important role of neuronal electric activ‐
ity in secretion of these microRNAs. Incubation of macrophages with exogenous 
miR‐124 resulted in efficient translocation of miR‐124 into the cytoplasm. This study 
demonstrates an important role of neuronal miRNAs in communication of neurons 
with microglia, which favors the hypothesis that microglia acquire a specific pheno‐
type under the influence of the CNS microenvironment.
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1  | INTRODUC TION
It is currently accepted that the central nervous system (CNS) pos‐
sesses a specialized immunosuppressive microenvironment for im‐
mune cells such as macrophages, which often demonstrate a low 
level of activation in the normal CNS and even during various pa‐
thologies such as neuroinflammation. Within the CNS, the immune 
response is typically self‐limited when compared to other organs in 
the periphery (Fabry, Schreiber, Harris, & Sandor, 2008; Ponomarev, 
Maresz, Tan, & Dittel, 2007; Ponomarev, Veremeyko, & Weiner, 
2013). Microglia are CNS‐resident immune cells that belong to the 
class of tissue‐resident macrophages and exhibit a deactivated 
phenotype in the normal CNS with low levels of activation mark‐
ers MHC class II and CD45 (Ponomarev, Shriver, Maresz, & Dittel, 
2005). The mechanism involved in such deactivation of CNS‐resi‐
dent macrophages is still largely unknown. In our previous studies, 
we found that only microglia (but not other types of tissue‐resi‐
dent or blood‐derived macrophages) expressed neuronal microRNA 
miR‐124, which mediated their deactivated MHC class IIlowCD45low 
phenotype (Ponomarev, Veremeyko, Barteneva, Krichevsky, & 
Weiner, 2011). However, it remains unknown how the expression 
of miR‐124 is induced in microglia. We hypothesized that specific 
signals from neuronal cells induce miR‐124 in microglia, but it was 
not known how it was mediated at the molecular level (Ponomarev, 
Veremeyko, Barteneva et al., 2011; Ponomarev et al., 2013).
MicroRNAs are small (<25 nucleotides long) non‐coding RNAs 
that mediate many essential processes such as cell proliferation, 
differentiation, and modulation of activation of innate immune 
cells (Ponomarev et al., 2013). Because we found that neuronal mi‐
croRNA‐124 is expressed in CNS‐resident microglia but not in pe‐
ripheral macrophages (Ponomarev, Veremeyko, Barteneva et al., 
2011), we hypothesize that there is a horizontal transfer of neuronal 
microRNAs from neurons to microglia. For transfer of miRNA‐124 
from one cell to another within the CNS, these miRNAs should be 
relocated from the cytoplasm of a donor cell into the extracellular 
space, and then transported from the extracellular space into the cy‐
toplasm of the recipient cell. Indeed, it was discovered that extracel‐
lular microRNAs (ECmiRNAs) are present in many biological liquids 
such as plasma, cerebrospinal fluid, saliva, and tears. There are three 
main known pathways of ECmiRNA secretion: (a) exosomes, (b) miR‐
NA:Ago2 complexes, and (c) miRNA:HDL complexes (Sohel, 2016).
In addition to miR‐124, the neuronal microRNA miR‐9 is ex‐
pressed at a very high level in neurons (Coolen, Katz, & Bally‐Cuif, 
2013). Both miR‐124 and miR‐9 are predominantly expressed by neu‐
rons but not glial cells (Coolen et al., 2013; Ponomarev, Veremeyko, 
Barteneva et al., 2011; Rao et al., 2016). MiR‐9 regulates many pro‐
cesses of neurogenesis via targeting important transcription fac‐
tors such as Foxgp1, Foxp1, and Foxp2 (Radhakrishnan & Alwin Prem 
Anand, 2016). Along with miR‐124, miR‐9 is a key regulator of neu‐
ronal differentiation (Krichevsky, Sonntag, Isacson, & Kosik, 2006). 
Both miR‐124a and miR‐9 negatively regulate phosphorylation of 
STAT3, which inhibits neuronal terminal differentiation (Krichevsky 
et al., 2006). Outside of the CNS, miR‐9 is expressed in lipopoly‐
saccharide‐activated macrophages (Liu & Abraham, 2013) and is 
involved in regulation of expression of interferon‐regulated genes 
such as MHC class I, IL‐1, and IL‐6 (Gao et al., 2013). Thus, miR‐124 
and miR‐9 could play an important role in modulating the functions 
of innate immune cells in the CNS microenvironment.
The most studied pathway is the secretion of miRNA via exo‐
somes and other types of cell‐derived microparticles. Many types 
of miRNA have been found in small cell vesicles of 30–90 nm (exo‐
somes), as well as larger (100–1,000 nm) microparticles that are 
produced by many cell types, including neurons (Barteneva et al., 
2017, 2013 ; Zhang et al., 2015). Neuronal cells secrete a large num‐
ber of exosomes, which originate from endosomes via an internal 
budding process and formation of multivesicular bodies comprising 
endosomes containing multiple exosome vesicles (Chivet, Hemming, 
Pernet‐Gallay, Fraboulet, & Sadoul, 2012; Zhang et al., 2015). Fusion 
of endosomes with the plasma membrane results in the release 
of multiple exosomes into the extracellular space. In neurons, en‐
dosomes are present in neuronal pre‐ and postsynaptic terminals 
(Cooney, Hurlburt, Selig, Harris, & Fiala, 2002). Postsynaptic neu‐
ronal terminals are enriched with multivesicular bodies that are in‐
creased by the synaptic (electric) activity of neurons (Kraev et al., 
2009; Stewart et al., 2005). Secreted exosomes are taken up by other 
cells via endocytosis, where exosomes could fuse with endosomal 
or outer plasma membranes, leading to translocation of miRNA into 
the cytoplasm of recipient cells (Zhang et al., 2015). Thus, exosomes 
could serve as a “parcel service” for miRNA transfer among the cells.
In addition to secretion of ECmiRNA via exosomes, miRNAs 
have been found in the extracellular space in complex with an Ago2 
protein and also in complex with high‐density lipoprotein (HDL) 
particles (Sohel, 2016). Ago2 is important for the chief functions 
of miRNA, namely RNA interference and gene silencing by forming 
RNA‐induced silencing complexes. In the cytoplasm, a large propor‐
tion of miRNA is in complex with Ago2. The mechanism of release of 
miRNA:Ago2 complexes is not clear (Sohel, 2016). Most likely these 
complexes are released from the cytoplasm into the extracellular 
Significance
In our study, we demonstrated phenomenon of the secre‐
tion of extracellular microRNAs by electrically active neu‐
rons. Neuronal microRNAs were present in the extracellular 
space in various forms such as in complex with high‐density 
lipoproteins (HDLs). HDL:miRNA complexes were effi‐
ciently transferred from the extracellular space into the cy‐
toplasm of macrophages. Horizontal transfer of miR‐124 
from neurons to microglia was also detected in vivo. Our 
study demonstrates that microglia/macrophages acquire a 
specific phenotype only under the influence of the CNS mi‐
croenvironment regardless of their origin from bone mar‐
row or yolk sac, a finding that may have future clinical 
applications to downmodulate neuroinflammation.
164  |     VEREMEYKO Et al.
space from necrotic or late apoptotic cells when the integrity of 
the plasma membrane becomes compromised (Turchinovich, Weiz, 
Langheinz, & Burwinkel, 2011) In contrast to Ago2, miRNA:HDL 
complexes are secreted by live cells under physiological conditions 
via an unknown mechanism. HDLs are abundant in the blood circu‐
lation and are also present in the CNS, where they are mostly pro‐
duced by astrocytes and microglia (Vitali, Wellington, & Calabresi, 
2014). MiRNA:HDL complexes are taken up by other cells such as 
macrophages or hepatocytes via scavenger SR‐BI receptors (Vickers, 
Palmisano, Shoucri, Shamburek, & Remaley, 2011). The mechanism of 
release from miRNA:HDL complexes is not clear, but it is known that 
miRNA could bind to the internal part of dense detergent‐resistant 
membrane domains (also referred to as lipid rafts) during the process 
of exosome budding (Janas, Janas, Sapoń, & Janas, 2015; Michell & 
Vickers, 2016; Vickers et al., 2011). Inhibition of the enzyme sphin‐
gomyelinase‐2, which cleaves glycosphingolipids in the areas of lipid 
rafts, increased the number of HDL:miRNA complexes (Michell & 
Vickers, 2016) and exosomes containing miRNA (Kosaka et al., 2010). 
MiRNA has the ability to bind glycolipids in complex with HDL via 
divalent cation binding (Janas et al., 2015; Janas, Janas, & Yarus, 
2006; Khvorova, Kwak, Tamkun, Majerfeld, & Yarus, 1999). Thus, 
miRNA has the ability to bind to HDL‐associated lipids, as well as in‐
ternal and external parts of cell plasma membranes, especially areas 
of glycosphingolipid‐enriched lipid rafts. Postsynaptic terminals are 
significantly enriched with neuronal lipid rafts found in the area of 
post‐synaptic density (Ponomarev, 2018; Sotnikov et al., 2013) and 
may also serve as an additional external site for miRNA binding for 
subsequent release into the extracellular space via shedding and/or 
enzymatic cleavage of glycosphingolipids (e.g., sphingomyelinase, β‐
galactosidase) (Janas et al., 2015, 2006; Khvorova et al., 1999).
In this study, we tested our hypothesis that there is a horizon‐
tal transfer of neuron‐specific microRNAs miR‐124 and miR‐9 from 
neurons to microglia and macrophages in normal CNS, which deter‐
mined deactivated phenotype of monocytic cells in CNS microenvi‐
ronment. We also investigated possible molecular mechanism of this 
phenomenon.
2  | MATERIAL S AND METHODS
2.1 | Mice
C57BL/6 (B6; RRID: IMSR_JAX:000664) and B6.ACTB‐DsRed (B6.
Cg‐Tg(CAG‐DsRed*MST)1Nagy/J; RRID: IMSR_CMMR:0071) trans‐
genic (DsRed tg) mice were originally purchased from the Jackson 
Laboratory (Bar Harbor, ME) and bred locally at the Laboratory 
Animal Services Center (LASEC) at the Chinese University of Hong 
Kong. The study was performed in accordance with the recommen‐
dations of the ARRIVE guidelines (https://www.nc3rs.org.uk/arrive‐
guidelines). Animal protocols were approved by the Department of 
Health of the Government of Hong Kong and the Chinese University 
of Hong Kong Animal Experimentation Ethics Committee. Animals 
were housed under strictly controlled environment (temperature 
and humidity) with automatic 12‐hr light/dark cycle and were fed 
ad libitum. Animals were provided with housing cages (4–5 animals 
of the same sex per cage) and bedding, which was changed daily. 
All materials and personnel were passed through a decontamina‐
tion and/or sterilization process before entering animal facility. For 
all experimental procedures, we used both male and female mice of 
different age for different procedures, which is specified below. For 
preparation of bone marrow or brain slices the animals were sacri‐
ficed by CO2 overdose followed by cervical dislocation. For prepa‐
ration of microglia or sections for immunofluorescene, mice were 
anasthesized with lethal dose of isofluran for the subsequent intra‐
cardial whole‐body perfusion with PBS. Mouse embrions were anal‐
gised by placing on ice and euthnized by swift decapitation.
2.2 | Cells
Bone marrow‐derived macrophages (BMDMs) were grown in the 
presence of macrophage colony‐stimulating factor (M‐CSF), as de‐
scribed earlier in our studies (Ponomarev, Veremeyko, Barteneva et 
al., 2011; Veremeyko, Siddiqui, Sotnikov, Yung, & Ponomarev, 2013). 
Bone marrow from 6‐ to 8‐week‐old B6 mice (combining equal num‐
ber of males and females; n = 3–4 males and n = 3–4 females per ex‐
periment) was isolated by flushing, and a single‐cell suspension was 
obtained by passing the cell suspension through a 70‐μm cell strainer 
(Falcon). Yolk sac‐derived macrophages (YSDMs) were grown in M‐
CSF, much as with BMDMs. Briefly, yolk sacs were isolated from 
day 10–11 mouse embryos of both sexes (approximately 4–6 male 
and 4–6 female embryos per experiment), homogenized by pass‐
ing through a 26 g needle of a 1‐ml syringe. The cell suspension was 
passed through a 70‐μm cell strainer and re‐suspended in culture 
medium. BMDMs and YSDMs were grown in DMEM culture media 
(Gibco) supplemented with 10% FBS (Gibco) and 10 ng/ml M‐CSF 
(R&D) for 5 days. Media were replaced after every 2–3 days. After 
5 days, the cells were used for experiments. FACS analysis indicated 
a homogeneous population of YSDMs with 90%–95% F4/80‐positive 
macrophages (data not shown). Adult microglia were isolated from 
the CNS of equal numbers of male and female 6‐ to 7‐week‐old B6 
mice (combining n = 3 males and n = 3 females per experiment) using 
a 40%/70% Percoll gradient and grown in the presence of M‐CSF 
(10 ng/ml) as described in our earlier studies (Dukhinova, Kopeikina, 
& Ponomarev, 2018; Ponomarev, Novikova, Maresz, Shriver, & Dittel, 
2005). Mouse cortical neurons were prepared from prenatal day 
17–18 embryos of both sexes (combining n = 4–6 males and n = 4–6 
females per experiment) as also described in our previous studies 
(Wong et al., 2013). Neuronal cultures contained 85%–90% neu‐
rons, 10%–15% astroglia, and an undetectable number of microglia, 
as determined by staining for β3‐tubulin, GFAP, and CD11b or Iba1, 
respectively (see information about antibodies below). Brain slice 
organotypic cultures (thickness: 500 μm) were obtained from equal 
numbers of male and female B6 mice aged 4–5 weeks (combining 
n = 3–4 males and n = 3–4 females per experiment) and were treated 
similarly as described (Kellner et al., 2014). Cortical neuronal cells or 
brain slices were cultured using a neurobasal medium with B27 sup‐
plement, 0.5% glutamate, and 1% penicillin/streptomycin (no AraC 
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treatment), and used at 10–14 days in vitro. Co‐culture of primary 
cortical neurons with BMDMs was performed in neurobasal medium 
in the presence of M‐CSF (10 ng/ml). Co‐culture of neurons with 
BMDM did not markedly reduce neuronal and macrophage viability, 
as determined by staining for the neuronal and macrophage mark‐
ers β3‐tubulin and CD11b before and after co‐culture. The neuronal 
cell line N1E115 (mouse neuroblastoma) was purchased from ATTC 
(cat# CRL‐2263; RRID: CVCL_0451) and cultured in DMEM with 10% 
FBS. Cell viability was measured by a bioluminescent kit from Abcam 
(cat#ab65314).
In our study, we used the cells from both sexes, but we did 
not specifically investigate gender difference. To exclude sex as a 
TA B L E  1   Antibody characterization
The name of the antibody (host 
species, clonality, specificity)
Immunogen (species 
recognized)
Description (manufacturer, catalog 
number, RRID, control conditions)
The initial concentra‐
tion and dilution
Rat anti‐mouse monoclonal anti‐
CD11b‐AF488 antibodies (clone 
M1/70)
Macrophages marker 
CD11b (mouse, human)
BD Biosciences, cat# 557672, RRID: 
AB_396784, control: absence of binding to 
CD11b‐negative cell subsets (lympho‐
cytes) as determined by FACS
0.2 mg/ml, dilution 
1:100
Goat polyclonal anti‐human/rat/mouse 
antibodies for Iba1
Iba1/AIF1 (C‐TERMINAL) 
NP_116573.1; 
NP_001614.3 (mouse, 
human, rat, pig)
BioRad, cat#AHP2024, RRID: AB_2224406, 
control: absence of binding to Iba‐negative 
cell subsets (neurons, astrocytes) as 
determined by immunofluorescence
0.5 mg/ml, dilution 
1:200
Donkey polyclonal anti‐goat IgG 
antibodies conjugated with AF488
Goat IgG (H + L) (goat) Jackson ImmunoResearch, cat# 
705‐546‐147, RRID: AB_2340430, 
control: antibodies have minimal cross 
reactivity to chicken, guinea pig, Syrian 
hamster, horse, human, mouse, rabbit, and 
rat serum proteins
1 mg/ml, dilution 1:500
Mouse monoclonal AF488‐conjugated 
antibodies for human/mouse/rat 
GFAP (clone GA5)
Glial Fibrillary Acidic 
Protein (human, mouse, 
rat)
EMD Millipore, cat#mab3402X, RRID: 
AB_11210273, control: absence of binding 
to GFAP‐negative cell subsets (neurons, 
microglia) as determined by 
immunofluorescence
1 mg/ml, dilution 
1:1,000
Rabbit polyclonal anti‐human/mouse/
rat antibodies for β3‐tubulin
Beta III Tubulin (human, 
mouse, rat)
EMD Millipore, cat#ab15708A4; RRID: 
AB_10916541, control: absence of binding 
to β3‐tubulin ‐negative cell subsets 
(astrocytes, microglia) as determined by 
immunofluorescence
1 mg/ml, dilution 
1:1,000
Rat monoclonal anti‐mouse MHC class 
II‐PE‐Cy5 (clone MS/114.15.2)
MHC Class II (I‐A/I‐E) 
(mouse)
eBioscience, cat# 14‐5321‐81, RRID: 
AB_467560, control: absence of binding to 
MHC class II‐negative cell subsets (T 
lymphocytes) as determined by FACS
0.2 mg/ml, dilution 
1:200
Rat monoclonal anti‐CD45‐APC‐Cy7 
(clone 30‐F11)
CD45 (mouse) BioLegend; cat# 103115, RRID: 
AB_312980, control: absence of binding 
to CD45‐negative cells (astroglial cell line) 
as determined by FACS
0.2 mg/ml, dilution 
1:100
Rat monoclonal anti‐F4/80‐AF488 
(clone BM8)
F4/80 (mouse) BioLegend, cat# 12312, RRID: AB_893479, 
control: absence of binding to F4/80‐neg‐
ative cell subsets (lymphocytes) as 
determined by FACS
0.5 mg/ml, dilution 
1:200
Rat monoclonal antibodies specific for 
mouse Fc receptors CD16/CD32 
(clone 2.4G2)
CD16/CD32 (mouse) BD Biosciences, cat# 553141, RRID: 
AB_394656, control: these are blocking 
antibodies
0.5 mg/ml, dilution 1:50
Rabbit polyclonal antibodies for 
human/mouse/rat HDLs
KLH conjugated synthetic 
peptide from a 41–125 
amino acid sequence of 
human HDL (human, 
mouse, rat)
Biorbyt, cat#orb1003, RRID: AB_2737031, 
control: absence of non‐specific bands on 
the western blot
0.5 mg/ml, dilution 
1:1,000
Rabbit monoclonal anti‐human/
mouse/rat TSG101 antibodies
Synthetic peptide from a 
1–100 amino acid 
sequence of human 
TSG101 (human, mouse, 
rat)
Abcam, cat#ab125011, RRID: 
AB_10974262, control: absence of 
non‐specific bands on the western blot
1 mg/ml, dilution 
1:1,000
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biological variable for macrophages in culture, we combined equal 
(bone marrow) or comparable (yolk sac) numbers of males and fe‐
males as a source of isolated cells.
2.3 | Reagents
Proteinase K, β‐galactosidase, monensin, ionomycin, and sodium 
azide (NaN3) were purchased from Sigma. RNase was purchased 
from Thermo Fischer Scientific (cat# EN0531). Tetrodotoxin (TTX) 
was purchased from Abcam.
For treatment of NCM or brain slice conditioned medium 
(BSCM), proteinase K, and RNase were used at final concentrations 
of 10 U/ml and 100 μg/ml, respectively, for 1 hr at 37°C. Exosomes 
were isolated using total exosomes isolation kit from Invitrogen 
(cat#4478359), according to the manufacturer’s recommendations.
For treatment of cultured neurons, NaN3 and monensin were 
used at final concentrations of 10 nM and 2 μM, respectively. RNase 
was used at a final concentration of 100 μg/ml. TTX was used at a 
final concentration of 1 μM as described earlier (Takada, Yanagawa, & 
Komatsu, 2005). β‐Galactosidase was used at a concentration of 10 U/
ml, similarly as described in our earlier studies (Sotnikov et al., 2013).
2.4 | Antibody characterization
Rat anti‐mouse monoclonal anti‐CD11b‐AF488 antibodies (clone 
M1/70) that recognize macrophages marker CD11b (Veremeyko et 
al., 2018) were purchased from BD Biosciences (0.2 mg/ml, dilution 
1:100; RRID: AB_396784). Goat polyclonal anti‐human/rat/mouse 
antibodies for Iba1 (NP_116573.1; NP_001614.3) were purchased 
from BioRad (cat#AHP2024; 0.5 mg/ml, dilution 1:200; RRID: 
AB_2224406) and were used with secondary donkey anti‐goat 
IgG antibodies conjugated with AF488 (Jackson ImmunoResearch, 
cat#705‐546‐147, RRID: AB_2340430). Mouse monoclonal AF488‐
conjugated antibodies for human/mouse/rat GFAP (clone GA5) 
were purchased from EMD Millipore (cat#mab3402X; 1 mg/ml, dilu‐
tion 1:1,000; RRID: AB_11210273). Rabbit polyclonal anti‐human/
mouse/rat antibodies for β3‐tubulin (cat#ab15708A4; 1 mg/ml, 
dilution 1:1,000; RRID: AB_10916541) were purchased from EMD 
Millipore. For more technical information regarding antibodies 
please refer to the Table 1.
2.5 | Flow cytometry and cell sorting
For analysis of BMDMs, the cells were obtained from DsRed tg mice 
and stained with rat anti‐mouse monoclonal anti‐MHC class II‐PE‐
Cy5 (eBioscience; clone MS/114.15.2; 0.2 mg/ml, dilution 1:200; 
RRID: AB_467560), anti‐CD45‐APC‐Cy7, (BioLegend; clone 30‐F11; 
0.2 mg/ml, dilution 1:100; RRID: AB_312980), and anti‐F4/80‐AF488 
(BioLegend; clone BM8; 0.5 mg/ml, dilution 1:200; RRID: AB_893479) 
as described earlier (Ponomarev, Tarasenko, & Sapozhnikov, 2000; 
Starossom, Veremeyko, Dukhinova, Yung, & Ponomarev, 2014; 
Veremeyko et al., 2018). F4/80+DsRed+ gated macrophages were 
sorted from neuronal co‐cultures or analyzed for the expression of 
MHC class II and CD45. Fc receptors were blocked with a mono‐
clonal antibodies specific for mouse Fc receptors (clone 2.4G2; BD 
Biosciences; 0.5 mg/ml, dilution 1:50; RRID: AB_394656). For more 
technical information regarding antibodies please refer to the Table 1.
For analysis of expression of activation markers, we used an 
LSRFortressa cytometer (BD Biosciences) (Dukhinova et al., 2018). 
For cell sorting, we used FACSAria 3 (BD Biosciences) (Kopeikina, 
Dukhinova, & Ponomarev, 2018). For data analysis FlowJo (RRID: 
SCR_008520) software was used.
2.6 | Biochemical characterization of neuronal 
conditioned medium
Neuronal conditioned medium (NCM) was collected from mouse 
cortical neurons cultured for 10 days. On day 11, neurons were 
placed in fresh neurobasal medium and cultured for 24 hr when 
the NCM was harvested. Similarly, BSCM was collected from brain 
slice organotypic cultures after 24 hr of culture in fresh neuroba‐
sal medium. After harvesting, NCM or BSCM were centrifuged at 
3,000 rpm and then passed through a 0.2‐μm filter (low protein 
binding membrane; Millipore) to eliminate cell debris. NCM or BSCM 
were further fractionated by using protein fractionation membranes 
for 3, 10, 30, 50, and 100 kDa (“Centurion”, Millipore). For further 
analysis, fractionated NCM or BSCM were treated with proteinase 
K (24 hr, 37°C), or RNase (24 hr, 37°C). NCM were also filtered using 
a stainless steel filter with a set of 100‐, 50‐, and 25‐nm nylon mem‐
branes (Millipore).
F I G U R E  1   High molecular weight neuronal soluble factors induce downregulation of CD45 and MHC class II and upregulation of miR‐124 
in macrophages. (a–c) Bone marrow‐derived macrophages (BMDMs) were obtained from DsRed transgenic mice as described in Materials and 
Methods and cultured alone (BMDMs alone), directly co‐cultured (co‐culture), or co‐cultured separately using a Transwell system (Transwell) 
with neuronal cell line (top contour plots and b) or primary cortical neurons (bottom contour plots and c) for 5 days and analyzed for the 
expression of DsRed, CD11b, CD45, and MHC class II using 4‐color cytometry. DsRed+CD11b+ gated macrophages were analyzed for the 
expression of CD45 (x‐axis) and MHC class II (y‐axis) (a), or FACS‐sorted DsRed+CD11b+ macrophages were used for isolation of RNA and 
analysis of miR‐124 expression by real‐time RT PCR as described in Materials and Methods (b, c). (d, e) Fractionation of neuronal conditioned 
medium (NCM) according to molecular weight and analysis of each fraction for the ability to induce expression of miR‐124 in macrophages. 
NCM (d) or brain slice conditioned medium (e; BSCM) were prepared and fractionated by size filtration as described in Materials and Methods. 
BMDMs were cultured alone in 50% neurobasal medium (untreated) or cultured in the presence of 50% non‐fractionated NCM (NCM‐all) 
or BSCM (BSCM‐all) or in fractionated NCM (<3; 3–30; 30–50; 50–100; >100 kDa) or BSCM (10–100; >100 kDa) for 4 hr and analyzed 
for miR‐124 expression by real‐time RT PCR as described in Materials and Methods. In (b–e), the median ± SD is shown on box and whisker 
plots (n = 4) with the mean value indicated by “+” symbol. The indicated differences were statistically significant as determined by one‐way 
ANOVA followed by Bonferroni post hoc test (**p < 0.01 for comparisons between two groups; b: F(2, 9) = 86.42, p < 0.0001; c: F(2, 9) = 
190.3, p < 0.0001; d: F(6, 21) = 216.7, p < 0.0001; e: F(3, 12) = 775.6, p < 0.0001) [Colour figure can be viewed at wileyonlinelibrary.com]
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2.7 | Quantitative real‐time RT PCR
For the analysis of miR‐124, miR‐9, miR‐155, and other miRNA ex‐
pressions (miR‐124*, miR‐9*, miR‐134, miR‐138), we used primers 
from Applied Biosystems and analyzed either by showing 40‐CT data 
(for conditioned media) or using snoRNA‐55 for normalization and 
the ΔΔCT method (for the cells) as described previously (Ponomarev, 
Veremeyko, Barteneva et al., 2011; Veremeyko, Starossom, Weiner, 
& Ponomarev, 2012).
2.8 | Western blotting
Western blot analysis was performed according to a standard pro‐
tocol as previously reported (Ponomarev, Veremeyko, Barteneva et al., 
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2011; Veremeyko et al., 2018). Rabbit polyclonal antibodies for 
human/mouse/rat HDLs (immunogen: KLH conjugated synthetic 
peptide from a 41–125 amino acid sequence of human HDL) were 
purchased from Biorbyt (cat#orb1003; 0.5 mg/ml, dilution 1:1,000; 
RRID: AB_2737031). Rabbit monoclonal anti‐human/mouse/rat 
TSG101 antibodies (immunogen: synthetic peptide from a 1–100 
amino acid sequence of human TSG101) were purchased from 
Abcam (cat#ab125011; dilution 1:1,000; RRID: AB_10974262). For 
more technical information regarding antibodies please refer to the 
Table 1.
2.9 | Exosome preparation
Exosome preparation was performed using a total exosome isolation 
kit from Invitrogen (cat#4478359) according to the manufacturer’ 
recommendations. This kit is optimized to isolate vesicles of sizes 
30–150 nm from culture supernatant by precipitating exosomes via 
centrifugation at 10,000 g.
2.10 | Fluorescent in situ microRNA hybridization 
(FISH) and immunofluorescence histology
Visualization of miR‐124 in macrophages and glial cells was per‐
formed by in situ hybridization as described (Planell‐Saguer, Rodicio, 
& Mourelatos, 2010; Ponomarev, Veremeyko, & Barteneva, 2011). 
BMDMs were seeded on glass slides and fixed in freshly prepared 
4% paraformaldehyde (PFA) in PBS for 30 min and then stored in 
PBS until the FISH procedure.
Brains were isolated from male (n = 3) and female (n = 3) of 8‐ 
to 12‐week‐old C57BL/6 mice following isoflurane overdose and 
whole‐body perfusion with PBS and then with 1% PFA. Tissue was 
fixed in 1% PFA (24 hr) and 30% sucrose (3 days), then transferred 
into TissueTek and sectioned on a cryotome to prepare 10‐µm‐thick 
histology sections.
Biotin labeling LNA probe (Exiqon) for detection of mi‐
croRNA‐124 (bio‐3′‐ATCAAGGTCCGCTGGAACA‐5′‐bio) was mixed 
with the following: 50% formamide, 10% dextran sulfate, 100 ng of 
miRNA in 2× SSC and applied to glass slides with fixed cells. Probe 
hybridization was performed at 60°C (melting temperature (Tm) is 
77°C), 15 min for cultured macrophage culture and 30 min for brain 
histology sections. Post‐hybridization washes consisted of the wash 
with 4× SSC and then with 2× SSC (5 min each at 60°C). The slides 
were then rinsed three times in TNT solution (0.1 M Tris‐HCl, 0.15 M 
NaCl) at room temperature, and then used for visualization using 
Cy3‐labeled TSA fluorescence detection systems according to the 
company’s recommendation (PerkinElmer).
Subsequently, samples were processed for immunostaining to 
detect microglia (Iba1‐positive cells) and astrocytes (GFAP‐positive 
cells) in brain histology sections, or for labeling cell membranes of 
cultured macrophages. FITC‐labeled Cholera Toxin B subunit (CTB‐
FITC; 1:100; Sigma) was used to label ganglioside GM1 on the cell 
membrane of cultured macrophages. All slides were counterstained 
with DAPI and mounted in an anti‐fade solution (Vectashield; Vector 
Laboratories, Burlingame, CA, USA). Image acquisition was performed 
using an Olympus FV1000‐ZCD Laser Scanning Confocal System 
(RRID: SCR_012365), with 60× objective, 1× and 2.5× magnification. 
Final image adjustments were performed using Adobe Photoshop 
CS2 (RRID: SCR_014199) and Image J (RRID: SCR_003070) software.
2.11 | Statistical data analysis
The results are presented as mean or median ± standard deviation 
(SD). Unpaired Student’s t test was used to determine significance be‐
tween two independent groups. Paired Student’s t test was used for 
the same samples before and after treatment or for the same sample. 
One‐way ordinary or repeated measures ANOVA with or without 
Bonferroni post hoc test were used to determine statistical signifi‐
cance for experiments with three or more experimental groups. P val‐
ues of less than 0.05 were considered significant. SigmaPlot (RRID: 
SCR_003210) and GraphPad Prism (RRID: SCR_002798) programs 
were used for the creation of the graphs and performing statistical 
analysis. Cumulative (integral) area under miRNA expression curves 
TA B L E  2   Quantitative analysis of the expression of activation markers MHC class II and CD45 on macrophages cultured alone, directly 
co‐cultured with neuronal cells, or cultured with neuronal cells using transwell system†
Neuronal cells BMDM alone (no co‐culture)
Direct co‐culture with neuronal 
cells
Co‐culture with neuronal cells using a transwell 
system
Neuronal 42 ± 10 11 ± 3** 16 ± 3**
Cell
Line (N1E115)
Primary 9 ± 2** 10 ± 2**
Cortical
Neurons
†Bone‐marrow‐derived macrophages (BMDM) were cultured alone (no co‐culture), directly co‐cultured with neuronal cell line N1E115 and primary 
cortical neurons, or co‐cultured with neuronal cells using a transwell system as for Figure 1a and the percentages of MHC class II+CD45+ double‐posi‐
tive cells is shown. Mean ± SD of separate experiments is shown (n = 3). **The difference is statistically significant when compared to BMDM cultured 
alone as determined by one‐way ANOVA (F(2,10) = 24,7; p < 0.0001) followed by Bonferroni post hoc test (p < 0.01 for single comparisons between 
two groups). 
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was calculated using the specific script for Excel software. All initial 
samples were coded with numbers to ensure randomization and mini‐
mize subjective bias when performing further sample processing and 
analysis using real‐time RT PCR or flow cytometry.
3  | RESULTS
3.1 | Neuronal soluble factors deactivate 
macrophages and upregulate miR‐1240
We have previously found that co‐culture of neuronal cell line 
N1E115 (mouse neuroblastoma) with mouse BMDMs resulted in 
downregulation of a number of activation markers (MHC class II 
and CD45) and upregulation of miR‐124 (Ponomarev, Veremeyko, 
Barteneva et al., 2011). We also found that transfection of BMDMs 
with miR‐124 resulted in downregulation of MHC class II and CD45 
via targeting of CEBPα and PU.1 transcription factors (Ponomarev, 
Veremeyko, Barteneva et al., 2011). This suggested that neuronal 
cells could provide direct cell‐contact or soluble‐factor signals 
to macrophages to cause upregulation of miR‐124 in microglia/
macrophages and downregulation of MHC class II and CD45 
(Ponomarev et al., 2013). However, it was not determined whether 
soluble factors from primary neurons could cause a similar effect 
in terms of deactivation and upregulation of miR‐124. To investi‐
gate this, we used co‐cultures of BMDMs with the NE1115 neu‐
ronal cell line and with mouse primary cortical neurons. Transwell 
co‐culture systems were also used to identify the role of neuronal 
soluble factors in the regulation of expression of MHC class II, 
CD45, and miR‐124. We found that both neuronal line and primary 
cortical neurons downregulated MHC class II and CD45 (Figure 1a). 
Moreover, it was sufficient to have soluble factors to induce MHC 
class IIlowCD45low phenotype in macrophages (Figure 1a, Transwell). 
Soluble factors from both neuronal cell line (Figure 1b) and primary 
cortical neurons (Figure 1c) were also sufficient to induce expres‐
sion of miR‐124 in BMDMs. The quantitative analysis is shown 
in Table 2. Thus, neuronal soluble factors induced expression of 
miR‐124 in macrophages, which was associated with their deacti‐
vated phenotype.
3.2 | High molecular weight fractions of 50–100 and 
>100 kDa of neuronal conditioned media induced 
miR‐124 in macrophages
To further characterize neuronal soluble factors, we used neu‐
ronal conditioned media (NCM), which was added (1:1) to 
BMDMs. As an untreated control, we added (1:1) fresh medium 
when primary neurons or neuronal line were incubated. We found 
that NCM upregulated miR‐124 in macrophages. We investigated 
whether NCM specifically induces miR‐124 in BMDMs or whether 
other abundant neuronal microRNAs such as miR‐9 could also 
be induced. We found that incubation of BMDMs with NCM re‐
sulted in 15.7‐fold upregulation of miR‐9 (not shown). Next, we 
performed fractionation of NCM and found that the most active 
fraction for miR‐124 induction was a high molecular weight frac‐
tion of >100 kDa followed by a smaller fraction of 50–100 kDa 
(Figure 1d). We have previously found that IL‐4 and IL‐13 (but nei‐
ther IL‐10 nor TGFβ1) upregulated miR‐124 in BMDMs, whereas 
IL‐10 and TGFβ1 deactivated macrophages. Because most of the 
regulatory cytokines that deactivate macrophages and/or induce 
miR‐124 (e.g., IL‐4, IL‐13, IL‐10, TGFβ), growth factors, and nu‐
trients have the relatively low molecular weight of <50 kDa, we 
hypothesized that somewhat larger molecular complexes sized at 
>50 kDa mediated expression of miR‐124 in macrophages. As an 
alternative to NCM, we used BSCM that was obtained from neu‐
ronal organotypic cultures. We found that, similar to NCM, BSCM 
also induced miR‐124 but to a higher degree—not surprising given 
F I G U R E  2   Comparison of expression of miR‐124 and miR‐155 
in bone marrow‐ and yolk sac‐derived macrophages under the 
influence of neuronal conditioned media. Bone marrow‐derived 
macrophages (BMDMs), yolk sac‐derived macrophages (YSDMs), or 
adult microglia were grown in the presence of M‐CSF as described 
in Materials and Methods. BMDMs and YSDMs were incubated in 
50% neurobasal media (YSDM and BMDM) or 50% NCM (YSDM 
+ NCM and BMDM + NCM) for 4 hr, and the expression levels of 
miR‐124 (a) and miR‐155 (b) were analyzed by real‐time RT PCR 
as described in Materials and Methods. The level of expression of 
miR‐124 and miR‐155 in YSDMs and BMDMs was compared to 
ex‐vivo isolated (AGM (ex vivo)) and cultured (AGM(culture)) adult 
microglia and ex‐vivo isolated peritoneal macrophages (PM (ex 
vivo)). In (a, b), mean ± SD of three separate experiments is shown 
on dotplots (n = 3; *p < 0.5; **p < 0.01; ***p < 0.001 as determined 
by unpaired Student’s t test) [Colour figure can be viewed at 
wileyonlinelibrary.com]
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the large numbers of both neuronal and glial cells in acute brain 
slice organotypic cultures (Figure 1e). Similar to NCM, a fraction 
of >100 kDa was the most effective in induction of miR‐124 in 
macrophages (Figure 1e). Taken together, these data indicate 
an important role of high molecular weight complexes in the in‐
duction of miR‐124 in macrophages. We also found that NCM 
induced expression of another neuronal microRNA (miR‐9) in 
macrophages.
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3.3 | Microglia express miR‐124 and miR‐9 only 
in the CNS microenvironment, whereas both 
bone marrow‐ and yolk sac‐derived macrophages 
upregulated miR‐124 after incubation with neuronal 
conditioned media
In our experiments, we used BMDMs to induce miR‐124 under 
the influence of NCM (Figure 1). However, it was established that 
microglia originate from yolk sac (YS) but not from bone mar‐
row (BM) (Ponomarev et al., 2013). Therefore, YS‐derived mac‐
rophages may react differently to NCM. Moreover, YS‐derived 
macrophages and adult microglia may have an intrinsic level of 
miR‐124 expression. To answer this question, we compared the 
level of miR‐124 expression in BM‐ and YS‐derived macrophages 
grown in M‐CSF and in ex vivo isolated and cultured adult micro‐
glia. We also measured the miR‐124 expression level in resident 
peritoneal macrophages, which are known to originate from BM. 
We found that cultured YS‐derived macrophages had an even 
lower level of expression of miR‐124 in comparison to BMDMs 
(Figure 2a, YSM vs. BMM). NCM induced miR‐124 in both BM‐ 
and YS‐derived macrophages to similar levels (Figure 2a, YSM 
+ NCM vs. BMM + NCM). Ex vivo isolated adult microglia, but 
not peritoneal macrophages, had the highest level of miR‐124 
(Figure 2a, AMG (ex vivo) versus PM (ex vivo)). However, when 
adult microglia were cultured in the presence of M‐CSF for 
several weeks, these cells dramatically decreased their level of 
miR‐124 to the level of BM‐derived macrophages (Figure 1a, 
AMG (culture)). Ex vivo isolated microglia also expressed miR‐9, 
which was not detected in cultured adult microglia (not shown). 
We also investigated the expression of miR‐155, which was up‐
regulated in classically activated M1 macrophages and often op‐
poses the pattern of expression of miR‐124, which is expressed 
more in alternatively activated M2 macrophages (Ponomarev 
et al., 2013; Veremeyko et al., 2013, 2018 ). We found that NCM 
induced miR‐155 in YS‐, but not in BM‐derived macrophages. 
MiR‐155 was also upregulated in cultured adult microglia, and 
this microRNA was also expressed on peritoneal macrophages 
(Figure 2b). Thus, we found that neuronal soluble factors in‐
duced miR‐124 in both BM‐ and YS‐derived macrophages and 
that adult microglia expressed miR‐124 only in the context of the 
CNS microenvironment.
3.4 | Various protein:RNA complexes are present 
in the fraction of 30–100 kDa that are sensitive to 
RNase treatment
Next, we investigated the presence of miR‐124 in various fractions 
of NCM. As an additional neuronal miRNA that was upregulated 
in macrophages by NCM, we investigated miR‐9. The highest con‐
centrations of both miR‐124 (Figure 3a) and miR‐9 (Figure 3b) were 
found in the >100‐kDa fraction. However, lower molecular weight 
fractions (30–100, 10–30, and 3–10 kDa) contained both miR‐124 
and miR‐9 (Figure 3a,b). Fractions 30–100 and 10–30 kDa also con‐
tained many other types of neuronal miRNAs besides miR‐124 and 
miR‐9: miR‐124* (Figure 3c), miR‐9* (Figure 3d), miR‐155 (Figure 3e) 
and miR‐134 (Figure 3f). We investigated whether fractions 30–100 
and 10–30 kDa were sensitive to RNase treatment. We found that 
the fraction of 30–100 kDa was sensitive to RNase treatment, 
leading to a 2‐ to 3‐fold decrease in miR‐124 (Figure 3g) and miR‐9 
(Figure 3h) levels in the 30–100‐kDa fraction. Of interest, the 
10–30‐kDa fraction was less sensitive to RNase treatment. This in‐
dicates that there are smaller proteins of specific conformation and/
or double‐stranded RNA formations that block RNase from digesting 
these miRNAs.
To demonstrate that proteins do form complexes with miR‐124 
or miR‐9, we enzymatically treated 30–100‐kDa complexes with 
F I G U R E  3   Analysis of the level of expression, RNase sensitivity, and adsorption to proteins of neuronal microRNAs miR‐124, miR‐9, 
miR‐124*, miR‐9*, miR‐155, and miR‐134 in various fractions of neuronal conditioned medium (NCM). NCM was harvested from cultured 
neurons, fractionated by size filtration, and then further used as untreated (a–f) or treated with RNase (g, h) or with proteinase (i, j), and 
analyzed for the expression of neuronal miRNAs as described in Materials and Methods. (a, b) Analysis of expression of miR‐124 (a) and 
miR‐9 (b) in unfractionated NCM (NCM‐all) and in a fraction of >100 kDa (>100 kDa), and fractions of 30–100, 10–30, and 3–10 kDa. (c–f) 
Analysis of the expression of miR‐124* (c), miR‐9* (d), miR‐155 (e), and miR‐134 (f) in unfractionated NCM (NCM‐all) in fractions of 30–100 
and 10–30 kDa. (g) Comparison of expression of miR‐124 in untreated NCM versus NCM treated with RNase in fractions of 30–100 and 10–
30 kDa. (h) Comparison of expression of miR‐9 in untreated NCM versus NCM treated with RNase in fractions of 30–100 and 10–30 kDa. 
(i) Comparison of expression of miR‐124 in untreated NCM versus NCM‐treated proteinase K in fractions of 30–100 and 10–30 kDa. The 
30–100‐kDa fraction (left) was used as untreated or treated with proteinase K and then passed through 30‐, 10‐, and 3‐kDa filters. The 
fractions that remained on the 30‐, 10‐, and 3‐kDa filters were analyzed for the expression of miR‐124. The 10–30‐kDa fraction (right) was 
used as untreated or treated with proteinase K and then passed through 10‐ and 3‐kDa filters. The fractions that remained on the 10‐ and 
3‐kDa filters were analyzed for the expression of miR‐124. (j) Comparison of the expression of miR‐9 in untreated NCM versus NCM treated 
with proteinase K in fractions of 30–100 and 10–30 kDa. The 30–100‐kDa fraction (left) was used as untreated or treated with proteinase 
K and passed through 30‐, 10‐, and 3‐kDa filters. The fractions that remained on the 30‐, 10‐, and 3‐kDa filters were analyzed for the 
expression of miR‐9. The 10–30‐kDa fraction (right) was used as untreated or treated with proteinase K and then passed through 10‐ and 3‐
kDa filters. The fractions that remained on the 10‐ and 3‐kDa filters were analyzed for the expression of miR‐9. In (a–j), mean ± SD of three 
separate experiments is shown on dotplots (n = 3). In (a–f), the indicated differences were statistically significant as determined by one‐way 
ANOVA followed by Bonferroni post hoc test (**p < 0.01 for comparisons between two groups; a: F(4, 10) = 1,177, p < 0.0001; b: F(4, 10) = 
7,154, p < 0.0001; c: F(2, 6) = 688.4, p < 0.0001; d: F(2, 6) = 3,243, p < 0.0001; e: F(2, 6) = 56.93, p = 0.0001; f: F(2, 6) = 196.9, p < 0.0001). 
In (g–j), the indicated differences were statistically significant as determined by unpaired Student’s t test (*p < 0.5; **p < 0.01; ***p < 0.001; 
*****p < 0.00001) [Colour figure can be viewed at wileyonlinelibrary.com]
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proteinase K and then passed them again through the same 
size 30‐kDa filter and smaller size (10 and 3 kDa) filters. Similar 
treatments were performed for 10–30‐kDa fraction, which we 
then passed through the 10‐ and 3‐kDa filters. We found that 
the amounts of miR‐124 (Figure 3i) and miR‐9 (Figure 3j) in the 
30–100‐kDa fraction were significantly decreased on the 30‐
kDa filter when these fractions were treated with proteinase 
K and then passed through the same filter when compared to 
the untreated control (Figure 3i,j; On 30 kDa). For miR‐124, the 
amount of this miRNA was increased on the 10‐kDa filter when 
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the 30–100‐kDa fraction was treated with proteinase K and then 
passed through the 10‐kDa filter. This indicates the passage of 
deproteinized miR‐124 through the 30‐kDa filter and retention 
of deproteinized miR‐124 on the 10‐kDa filter (Figure 3i,j; On 
10 kDa). At the same time, proteinase treatment of the 30–10‐
kDa fraction did not significantly affect the amount of miR‐124 
retained on the 10‐kDa filter (Figure 3i; On 10 kDa), indicating 
the presence of miR‐124 in the naked form in this fraction. In 
contrast to miR‐124, proteinase treatment of the 30–100 and 
10–30‐kDa fractions decreased the amount of miR‐9 in all filters 
except for the 3‐kDa filter (Figure 3j; On 3 kDa). These results 
suggest that miR‐9 was probably present in single‐chain form 
of around 7 kDa that passed through the 10‐kDa filter but was 
retained on the 3‐kDa filter. At the same time, miR‐124 proba‐
bly formed miR‐124:miR‐124* duplexes with molecular weight 
around 14 kDa, which is higher than 10 kDa, explaining the reten‐
tion of deproteinized miR‐124 on the 10‐kDa filter. An increase 
in the amount of proteinase K‐treated miR‐124 and miR‐9 on the 
3‐kDa filter indicates that dissociation of microRNAs from pro‐
teins facilitated their passage through the 30 and 10‐kDa filter 
and retention of naked RNA on 3‐kDa filter. Thus, our data indi‐
cate that the fraction of 30–100 kDa contains multiple protein 
complexes with miR‐124 and miR‐9, whereas the smaller fractions 
(10–30 kDa) contain deproteinized (naked) RNAs.
3.5 | The fraction of >100 kDa contains both 
protein:miR‐124 and protein:miR‐9 complexes and 
exosomes with miR‐9 and miR‐155
We further investigated the role of the >100‐kDa fraction, as this 
fraction demonstrated the most dramatic biological effect in the in‐
duction of miR‐124 in BMDMs (Figure 1d). A large fraction of more 
than 100 kDa may contain large protein:RNA complexes and micro‐
particles of various sizes that include microparticles (100–1,000 nm) 
and exosomes (30–90 nm). Because it is known that exosomes and 
larger microparticles contained miRNA, we performed filtration of 
NCM through 100‐, 50‐, and 25‐nm nylon filters. We found that 
only the 50‐ and 25‐nm filters decreased the level of miR‐155 and, 
to a lesser degree, miR‐9, but not miR‐124, miR‐134, and miR‐138 
(Figure 4a). These data indicate that NCM contain small exosomes 
with miR‐155 and miR‐9, whereas other neuronal microRNAs (e.g., 
miR‐124) were found in protein:RNA complexes. To verify that 
miR‐155 and miR‐9 but not miR‐124 were found in exosomes, we 
selectively isolated exosomes from both NCM and BSCM using a kit 
from Invitrogen (see Materials and Methods) and found that miR‐9 
and miR‐155 were enriched in the precipitated exosome fraction 
(Figure 4b). Thus, these data indicate that for the most of the studied 
microRNAs only proportion of them was enriched in exosomal frac‐
tion, with the exception of miR‐155. For miR‐155, about 80% of this 
miRNA was retained by 25 nm filter that eliminate exosomes, while 
for miR‐9 and miR‐124 these numbers were ~15% and ~5%, respec‐
tively (Figure 4a).
We further confirmed that the precipitated (pellet) fraction of 
exosomes expressed a high level of the neuronal exosome marker 
TSG101, which was also present in brain lysate (Figure 4c, Pellet 
and BL), whereas this exosomal marker was not detected in whole 
BSCM or in the non‐precipitated fraction of remaining supernatant 
(Figure 4c, BSCM and RSN). Further analysis demonstrated that 
miR‐155 and miR‐9, and, to a lesser degree, miR‐124* and miR‐9* were 
enriched in the exosomal fraction when compared to the remaining 
supernatant, which was not the case for miR‐124 (Figure 4d). It is 
quite clear from the filtration and exosome enrichment experiments 
that the size of exosomes in the conditioned media was in the range 
from 25 to 100 nm (Figure 4a; miR‐155; Figure 4d, miR‐155). Thus, 
miR‐155 was mainly co‐localized with exosomes; miR‐9, miR‐9*, and 
miR‐124* were found in both exosomes and remaining superna‐
tant, whereas miR‐124 was predominantly found in the remaining 
supernatant.
3.6 | MiR‐124 and miR‐9 form complexes with HDLs
Previous experiments led us to hypothesize that miR‐124 is prob‐
ably located in large protein:RNA complexes in NCM or BSCM. 
One of the known large protein complexes of the size >100 kDa 
F I G U R E  4   Analysis of the level of expression of neuronal microRNAs miR‐124, miR‐9, miR‐155, MiR‐134, and miR‐138 in microparticles 
and exosomes. (a) Neuronal conditioned medium (NCM) was harvested from cultured neurons as described in Materials and Methods and used 
unfiltered or passed through 100‐, 50‐ and 25‐nm filters and analyzed for the expression of miR‐124, miR‐9, miR‐155, miR‐134, and miR‐138. 
(b) NCM or brain slice conditioned medium (BSCM) were harvested from cultured neurons or organotypic brain slices, and exosomes 
were prepared as described in Materials and Methods. The levels of expression of miR‐124, miR‐9 and miR‐155 were measures for whole 
NCN (NCM‐all) or whole BSCM (BSCM‐all) versus exosomal fraction isolated from NCM (NCM‐exosomes) or BSCM (BSCM‐exosomes). (c) 
Western blot analysis of the expression of CNS exosomal marker TSG101 in the whole BSCM (15 μl), pellet (exosome preparation; 5 and 
10 μl), and remaining supernatant (RSN, 15 μl). Brain lysate was used as a positive control (BL, 5 μl). Exosomes were precipitated from 10 ml 
of BSCM using total exosome isolation reagent (from cell culture medium) as described in Materials and Methods. Pellet with exosomes 
was re‐suspended in 100 μl of Laemmli lysis buffer for electrophoresis and further western blot analysis. (d) Comparison of the level of 
expression of miR‐124, miR‐9, miR‐155, miR‐124*, and miR‐9* in the whole BSCM (BSCM‐all), pellet (exosomes), and remaining supernatant 
(Remaining SN). In (a, d), the mean ± SD of triplicate is shown on dotplot graphs (n = 3). The indicated differences were statistically significant 
as determined by one‐way ANOVA followed by Bonferroni post hoc test (**p < 0.01 for comparisons between two groups; a, miR‐124: F(3, 
8) = 27.96, p = 0.0001; a, miR‐9: F(3, 8) = 72.09, p < 0.0001; a, miR‐155: F(3, 8) = 208.1, p < 0.0001; a, miR‐134: F(3, 8) = 27.32, p = 0.0001; a, 
miR‐138: F(3, 8) = 44.65, p < 0.0001; d, miR‐124: F(2, 6) = 36.76, p = 0.0004; d, miR‐9: F(2, 6) = 5,018, p < 0.0001; d, miR‐155: F(2, 6) = 1,002, 
p < 0.0001; d, miR‐124*: F(2, 6) = 418.8, p < 0.0001; d, miR‐9*: F(2, 6) = 2,548, p < 0.0001). In (b), mean ± SD of quadruplicate is shown on 
dotplot graphs (n = 4; ****, p < 0.0001; unpaired Student’s t test) [Colour figure can be viewed at wileyonlinelibrary.com]
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are HDLs. HDLs are known to be present in the CNS, where they 
are produced by astrocytes and microglia (Vitali et al., 2014). It was 
reported that microRNA has the ability to bind to lipids within HDL 
complexes, which have the ability to translocate into the cytoplasm 
of recipient cells (Vickers et al., 2011). We looked at the fractions 
of BSCM of >100 and 10–100 kDa by western blot using anti‐
bodies that recognize 40‐kDa protein from HDL complexes. We 
found that HDLs were mostly present in the >100‐kDa fraction 
F I G U R E  5   Analysis of the level of expression of neuronal microRNAs miR‐124 and miR‐9 in HDL complexes. (a) Western blot analysis 
of the expression of 40‐kDa protein from HDL complexes in high molecular weight (>100 kDa) versus low molecular weight (10–100 kDa) 
fractions of BSCM. Ponseus S staining was used as a protein loading control. (b) Immunoprecipitation of HDL with miR‐124 and miR‐9. 
Anti‐HDL antibodies were adsorbed to plastic and >100‐kDa or 10–100‐kDa fractions of BSCM were added to antibodies as described in 
Materials and Methods. Expression of miR‐124 was assessed in HDLs bound to anti‐HDL antibodies (>100 kDa:HDL and 10–100 kDa:HDL) 
and in solution unbound to HDL in the >100 and 10–100‐kDa fractions (>100 and 10–100 kDa). (c, d) Comparison of expression of miR‐124 
(c) miR‐9 (d) in untreated BSCM versus BSCM treated with RNase (fractions of >100 and 10–100 kDa). In (b–d), mean ± SD of three separate 
experiments is shown on dotplots (n = 3; **p < 0.01; ***p < 0.001; ****p < 0.0001; ****p < 0.00001; unpaired Student’s t test) [Colour figure 
can be viewed at wileyonlinelibrary.com]
F I G U R E  6   Kinetics of extracellular production of miR‐124 and miR‐9 by cultured cortical neurons. (a) Primary mouse cortical neurons 
were cultured as described in Material and Methods. The medium was changed once at 0 hr time point, and the expression of miR‐124, miR‐9, 
and snoRNA‐55 were assessed 0.5, 1, 2, 4, 24, and 72 hr later by real‐time RT PCR as described in Materials and Methods. (b, c) Primary 
mouse cortical neurons were cultured as described in Material and Methods. The medium was changed 2 or 5 or 8 times, and expression of 
miR‐124 and miR‐9 (b) or neuronal viability (c) were assessed by real‐time RT PCR or bioluminescent viability kit, respectively, as described 
in Materials and Methods. (d, e) Primary mouse cortical neurons were used untreated and treated with β‐galactosidase for 30 min (d, e), and 
the expression levels of miR‐124 and miR‐9 (d) or neuronal cell viability (e) were assessed by real‐time RT PCR or bioluminescent viability 
kit, respectively, as described in Materials and Methods. In (a, b), mean ± SD of five separate culture wells is shown. In (b), ****p < 0.0001, 
as determined by repeated measures ANOVA test (miR‐124: F(2,12) = 84.5; miR‐9: F(2,12) = 45.2). In (d), mean ± SD of three separate cell 
culture wells is shown (***p < 0.001; ****p < 0.0001 when compared to the same sample before the treatment with β‐galactosidase; paired 
Student’s t test). In (c, e), mean ± SD of six separate cell culture wells is shown on box and whisker plot with the mean value indicated by “+” 
symbol [Colour figure can be viewed at wileyonlinelibrary.com]
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of BSCM and, to a much lesser degree, in the 10–100‐kDa frac‐
tion (Figure 5a). Similar results were found for NCM (not shown). 
Immunoprecipitation experiments further confirmed that miR‐124 
and miR‐9 were in complex with HDLs that were abundant in the 
>100‐kDa fraction (Figure 5b). When we treated a fraction of 
>100 kDa with RNase, we found that miR‐124 was resistant to 
RNase in this fraction (Figure 5c). At the same time, miR‐9 was 
slightly more sensitive to RNase treatment in this fraction but still 
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quite resistant (Figure 5d). These results suggest that miRNA:HDL 
complexes were mostly resistant to RNase treatment. Thus, most 
biologically active fractions of >100 kDa contained miR‐124:HDL 
complexes resistant to RNase.
3.7 | MiR‐124 and miR‐9 are promptly released from 
neuronal cells and gradually accumulated in the media
After characterization of various fractions of NCM and BSCM, we inves‐
tigated the kinetics of how miR‐124 and miR‐9 were produced by cul‐
tured cortical neurons. As a control, we used small snoRNA‐55, which 
is abundantly expressed in neuronal cells and is often used as a house‐
keeping RNA for normalization of expression of miRNA. Surprisingly, 
we found quite a high level of expression of miR‐9 and miR‐124 as early 
as 30 min of incubation of primary neurons in fresh neurobasal medium. 
At the same time, snoRNA‐55 was found in quite a low level (Figure 6a; 
0.5 hr). We checked the levels of expression of miR‐124, miR‐9, and 
snoRNA‐55 in fresh neurobasal medium and could not detect these 
molecules after 40 cycles of amplification (not shown). Thus, these mol‐
ecules appeared to be promptly released by cultured neuronal cells. The 
amounts of miR‐9 and miR‐124 were then gradually increasing during 
the 72‐hr period (Figure 6a; miR‐124 and miR‐9). In contrast to miR‐124 
and miR‐9, the level of snoRNA‐55 was increased after 4 hr of incuba‐
tion and then started to decline to reach a level at 72 hr similar to what it 
was after 1 hr of incubation (Figure 6a; snoRNA‐55). Thus, we concluded 
that miR‐124 and miR‐9 were not passively released from dead cells and 
accumulated in a nonspecific way as did the other short RNAs such as 
snoRNA‐55. Our data indicated a distinct pathway for secretion of neu‐
ronal microRNAs by cultured neurons.
3.8 | MiR‐124 and miR‐9 are accumulated on the 
surface of neuronal cells
We hypothesized that miR‐124 and miR‐9 were detected in high 
concentrations in media just after 30 min of incubation as a result 
of large depositions of these microRNAs on the cell surface. Several 
studies suggested that miRNA could bind lipids (Khvorova et al., 
1999), so we performed detection of miR‐124 and miR‐9 after 2, 5, 
and 8 changes of medium. Each time, cells were incubated in fresh 
medium for 1 min and before media were changed or collected for 
analysis of miR‐124 or miR‐9. Indeed, after 5 or 8 changes of me‐
dium, the concentrations of miR‐124 and miR‐9 were significantly 
decreased (Figure 6b). At the same time, 8 times changing of me‐
dium did not decrease neuronal viability (Figure 6c). This indicated 
that these microRNAs were washed out from cells. To further inves‐
tigate whether miR‐124 and miR‐9 were bound to the cell surface, 
we treated neuronal cells with β‐galactosidase to remove carbohy‐
drates from cell surface glycolipids and glycoproteins. Treatment of 
cells with β‐galactosidase for 30 min increased concentrations of 
snoRNA‐55, miR‐155, miR‐9, and miR‐124 in NCM (Figure 6d) and 
did not change neuronal viability (Figure 6e). Thus, miRNAs were 
present on the surface of cells, resulting in large depositions of 
these molecules on plasma membrane binding to glycolipids and 
glycoproteins.
3.9 | Monensin and ionomycin modulate the 
release of miR‐124 and miR‐9 by neuronal cells
It was reported that exosomes and HDL:miRNA complexes were re‐
leased through exocytosis (Vickers et al., 2011). To test whether this 
mechanism takes place in case of secretion of miR‐124 and miR‐9, 
we pre‐treated cells with the exocytosis inhibitor monensin or the 
exocytosis stimulator ionomycin for 30 min, changed media, and in‐
vestigated the accumulation of miR‐124 and miR‐9 in media within 
a 15‐min period. Before the treatment, the expression of miR‐124 
was the same across culture plates (not shown). Both monensin and 
ionomycin decreased the levels of miR‐124 (Figure 7a) and miR‐9 
(Figure 7b) when measured 1 min after changing of media. We found 
that monensin did not significantly decrease the rate of accumulation 
of miR‐124 or miR‐9, whereas ionomycin significantly enhanced it as 
determined by cumulative release during the 14‐min period from 1 
to 15 min of incubation (Figure 7c). At the same time, we found that 
ionomycin decreased neuronal viability by ~20%, whereas monensin 
decreased it by ~50% (Figure 7d). There is a possibility that dying 
neurons passively release miRNAs when treated with ionomycin. 
However, this was not likely, in that a more dramatic decrease in neu‐
ronal viability by monensin (Figure 7d, Monensin) did not significantly 
change miR‐124 and miR‐9 release (Figure 7c, Monensin). This result 
indicated that calcium influx induced by ionomycin stimulated secre‐
tion of miR‐124 and miR‐9.
F I G U R E  7   Influence of monensin, ionomycin, sodium azide, and RNase treatment on the level of extracellular production of miR‐124 
and miR‐9 by cultured cortical neurons. (a–d) Primary mouse cortical neurons were cultured as described in Materials and Methods. The cells 
were untreated or pre‐treated with ionomycin or monensin for 30 min, the media were changed to fresh media without or with ionomycin 
or monensin at the 0‐min time point, and the expression levels of miR‐124 (a), and miR‐9 (b) were assessed 1, 5, and 15 min later by real‐
time RT PCR as described in Materials and Methods. Cumulative values of miRNA release were calculated as area under curves for miRNA 
release from the 1 to 15 min period (see Materials and Methods) (c). Neuronal viability is shown in (d). (e–h) Primary mouse cortical neurons 
were cultured as described in Materials and Methods. The cells were untreated or pre‐treated with RNase or sodium azide for 30 min, the 
media was changed to fresh media without or with RNase or sodium azide at the 0‐min time point. The expression levels of miR‐124 (e) 
and miR‐9 (f) were assessed 5, 15, 30, 60, and 120 min later by real‐time RT PCR as described in Materials and Methods. Cumulative values 
of miRNA release (see Materials and Methods) are shown in (g), and neuronal viability is shown in (h). In (a–c, e–g), the mean ± SD of three 
separate experiments is shown (n = 3). In (d, h), the mean ± SD of 4–6 separate cell culture wells is shown on box and whisker plot with the 
mean value indicated by “+” symbol (n = 4–6). The indicated differences were statistically significant as determined by one‐way ANOVA 
followed by Bonferroni post hoc test (*p < 0.05 and **p < 0.01 for comparisons between two groups; c, miR‐124: F(2, 6) = 17.24, p = 0.0033; 
c, miR‐9: F(2, 6) = 114.6, p < 0.0001; d: F(2,10) = 31.4, p < 0.0001; g, miR‐9: F(2, 6) = 9.849, p = 0.0127) [Colour figure can be viewed at 
wileyonlinelibrary.com]
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3.10 | RNase and sodium azide treatments delay the 
release of miR‐124 and miR‐9 by neuronal cells
It was reported that most of the miRNA:protein complexes 
were protected from RNase treatment, whereas inhibition of 
mitochondria functions blocked the secretion of several types 
of ECmiRNAs (Wang, Zhang, Weber, Baxter, & Galas, 2010). We 
also investigated whether RNase or the mitochondria inhibitor 
NaN3 affects secretion of miR‐124 and miR‐9. We found that both 
agents decreased the rate of release of miR‐124 and miR‐9 within 
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a 5–15‐min period but had little effect in a long‐term perspective 
(15–120 min) (Figure 7e,f). Sodium azide did not significantly af‐
fect the cumulative release value for miR‐124 and miR‐9 during 
the 115‐min period from 5 to 120 min of incubation (Figure 7g). 
RNase did not affect the cumulative release value for miR‐124 but 
decreased the cumulative release of miR‐9 (Figure 7g). Neither 
RNase nor NaN3 decreased neuronal viability (Figure 7h). These 
data indicate that inhibition of mitochondria or RNase treatments 
delayed the release of miR‐124 and/or miR‐9 in the extracellular 
space but did not significantly affect this process in the long‐term 
perspective.
3.11 | Tetrodotoxin inhibits prompt release of 
miR‐124 and miR‐9 by neuronal cells
Because the electric activity of neurons is connected with calcium 
signaling and secretory activity of these cells (Stewart et al., 2005), 
we tested whether blocking of electric activity of neurons with 
TTX would inhibit the accumulation of extracellular miR‐124 and 
miR‐9. We pre‐treated cells with TTX for 24 hr and changed media 
5–6 times to remove miRNA from the surface of the cells. One 
minute after the last change of media, the levels of miR‐124 and 
miR‐9 were the same and there was no decrease in neuronal viabil‐
ity (not shown). However, accumulation of miR‐124 (Figure 8a,c) 
and miR‐9 (Figure 8b,c) was significantly decreased during the 
120‐min period in neuronal cells treated with TTX. At the same 
time, TTX did not decrease intracellular levels of expression of 
miR‐124 and miR‐9 (not shown). These data indicated that electric 
activity of neurons stimulated secretion of miR‐124 and miR‐9.
3.12 | Addition of BSCM or NCM to macrophages 
results in efficient translocation of miR‐124 from the 
cell surface to the cytoplasm
Finally, we investigated whether neuronal miR‐124 is translo‐
cated into the cytoplasm of macrophages and glial cells. We 
found that addition of BSCM to BMDMs resulted in the ac‐
cumulation of miR‐124 both on plasma membranes (labeled 
with CTB, which binds to GM1 ganglioside) and in the cyto‐
plasm of these cells (Figure 9a). At the same time, we did not 
detect expression of longer transcripts for pre‐miR‐124‐1, 
pre‐miR‐124‐2, and pre‐miR‐124‐3 after treatment of the cell 
with BMDMs, indicating that miR‐124 was not transcribed de 
novo but was instead translocated into the cytoplasm from 
BSCM.
To identify the similar process in vivo, we visualized miR‐124 
in Iba1‐positive microglia and GFAP‐positive astrocytes. We 
found miR‐124‐positive microglia and miR‐124‐positive astrocytes 
(Figure 9b, filled arrows) in brain histology sections. MiR‐124‐neg‐
ative microglia and astrocytes were also present (Figure 9b, open 
arrow). These data further demonstrated miR‐124 transfer from 
neuronal cells to astrocytes and neurons.
4  | DISCUSSION
In this study, we tested our hypothesis that the phenotype of mi‐
croglia in the CNS is determined by horizontal transfer of neuronal 
microRNAs from active neurons to microglia. We found that neu‐
rons secrete various microRNAs that have the ability to bind and 
enter the cytoplasm of monocytic cells both in vitro and in vivo. 
However, in contrast to the generally accepted point of view, most 
of the neuronal miRNAs were not only associated with exosomes 
but rather found in extracellular space in multiple forms includ‐
ing complexes with HDLs. Thus, this study highlights an important 
role of non‐exosomal ECmiRNAs in the communication of neurons 
with astroglia and microglia, which in turn, determine the pheno‐
type and function of these cells in the CNS. It is especially impor‐
tant in the case of microglia since our study strongly suggest that 
these cells acquire their deactivated MHC class IIlowCD45low in the 
CNS microenvironment upon communication with electrically ac‐
tive neurons.
To further understand the mechanism of horizontal transfer of 
miRNAs from neurons to microglia, we fully characterized neuro‐
nal extracellular microRNAs and found that miR‐124, miR‐9, and 
other neuronal miRNAs are present in the neuronal extracellular 
space in various forms: exosomes in complex with large protein 
particles such as HDL, in complex with smaller proteins, and in 
naked single‐ and double‐stranded forms. MiR‐124 and miR‐9 were 
constantly released by electrically active neurons, and this process 
involved mitochondrial activity, calcium signaling, and exocyto‐
sis. Extracellular miRNAs miR‐124 and miR‐9 were also present in 
large quantities on the surface of neuronal cells. These microRNAs 
were mostly protected from RNase and have the ability to bind 
to the surface and become internalized by other cell types such 
as macrophages/microglia. Inside the cell, miR‐124 is known to in‐
hibit the CEBPα‐PU.1 pathway (Ponomarev, Veremeyko, Barteneva 
et al., 2011), whereas miR‐9 inhibits NFκB in monocytic cells (Bazzoni 
et al., 2009). Both pathways are important for macrophage/mi‐
croglia activation and expression of activation markers such as 
MHC class II and CD45. Thus, horizontal transfer of miR‐124 and 
miR‐9 from neurons to microglia/macrophages deactivates them in 
the CNS (Figure 10).
We found that MiR‐9 was the most abundant ECmiRNA in cul‐
tured primary neurons. MiR‐9 was found in exosomes and in complex 
with proteins of smaller molecular weight. The second most abun‐
dant ECmiRNA was miR‐124, which was present in NCM in complex 
with HDLs, but not in exosomes. Prompt release of miR‐124 and 
miR‐9 was dependent on the electric activity of neurons and could 
be blocked by tetrodotoxin (TTX). MiR‐124 and miR‐9 were rapidly 
accumulated in the extracellular space even after several changes 
of media, and concentrations of these miRNAs were increased after 
treatment of neuronal cells with β‐galactosidase that digested glyco‐
calyx, suggesting large depositions of these microRNAs on the neu‐
ronal cell surface associated with glycolipids and/or glycoproteins. 
Accumulation of miR‐9 and miR‐124 was delayed by treatment with 
monensin and accelerated after treatment with ionomycin, indicating 
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the importance of the endosomal secretory pathway for secretion of 
these miRNAs. Microglia did not express miR‐124 and miR‐9 outside 
of the CNS microenvironment, whereas miR‐124 was detected in the 
CNS in microglia and astroglia. Thus, our data indicate an important 
role of extracellular microRNAs miR‐124 and miR‐9 in the communi‐
cation of neurons and glia.
Our study used small sample size numbers since we used stan‐
dardized in vitro systems where we combined together cultured 
cells or brain organotypic cultures isolated from several animals of 
the same genetic background of an equal/comparable number of an‐
imals for both sexes (n = 3–6 males and n = 3–6 females per experi‐
ment). These in vitro systems had low levels of variability and a high 
level of reproducibility. Indeed for the samples with reverse cycle 
values (40‐CT), the variability was very low with SDs in the range 
of less than 5% (from 1% to 4%). Therefore, n = 3 was sufficient for 
the standard level of confidence of 95% and statistical significances 
(Figures 3–4). For the samples with relative levels of miRNA expres‐
sions (Figures 1 and 2), SDs were higher than 5% (ranging from 8% 
to 66%) due to procedures of normalization to snoRNA‐55 for cul‐
tured macrophages and possibly other reasons. However, for these 
samples, the differences for mean values were quite dramatic (from 
5 to 20‐fold differences). A similar situation was observed for ex‐
pressions of MHC class II and CD45 on macrophages with SDs val‐
ues ranging from 18% to 22% and 2.6–4.7‐fold differences for mean 
values (Table 2). Therefore sample sizes of n = 3–4 were sufficient to 
observe statistically significant differences among compared groups 
for most of our experiments. However, it should be kept in mind 
that for each experiment we combined cultured cells isolated from 
n = 3–6 animals.
Secretion of miRNA into the extracellular space occurs via mul‐
tiple mechanisms: via formation of exosomes or microparticles, 
release from necrotic cells, or transport in complex with HDLs 
(Sohel, 2016). Other mechanisms are also possible for release of 
naked miRNAs. For example, specific RNA transporters SID‐1 and 
SID‐2 were found in C. elegance and Drosophila. SID‐1/2 channel 
proteins enable systemic RNA interference and transfer of dsRNA 
from one cell to another, with SID‐1 mediating release and SID‐2 
mediating uptake of regulatory RNA (McEwan, Weisman, & Hunter, 
2012; Shih, Fitzgerald, Sutherlin, & Hunter, 2009). Similar trans‐
porters with similar functions were recently found in humans and 
mice (Elhassan, Christie, & Duxbury, 2012; Nguyen et al., 2017). Our 
data indicate that miRNAs are released from neurons not in the con‐
text of microparticles, in that filtration through a 100‐nm filter did 
not decrease expression of most neuronal (miR‐124, miR‐9, miR‐9*, 
miR‐186) and other miRNAs (miR‐155). Filtration of NCM through 
a 25‐nm filter significantly decreased expression of miR‐155 and, 
to a lesser extent, miR‐9. By isolation of exosomes, we found that 
miR‐9 and miR‐155 were enriched in exosomes, along with miR‐9* 
and miR‐124*. On the other hand, almost all miR‐124 and a large 
proportion of miR‐9, along with miR‐124* and miR‐9*, were not as‐
sociated with exosomes. Our analysis demonstrated that in the frac‐
tion with molecular weight of >100 kDa, miR‐124 and miR‐9 were 
associated with HDLs. It is interesting that neurons do not produce 
their own HDLs, but these large protein complexes are produced by 
glial cells, which are present in neuronal cultures (Vitali et al., 2014). 
This fact suggests that miR‐124 and miR‐9 were probably secreted 
by neurons not in complex with HDLs but in complexes with other 
smaller proteins and/or in naked single‐ and double‐stranded forms. 
These neuronal ECmiRNAs most likely bind to glial HDLs in extracel‐
lular space. We found quite large proportions of miRNA in the low 
molecular weight fraction of 10–30 kDa of NCM. Moreover, exper‐
iments with treatment of the 10–30‐kDa fraction with proteinase 
and filtration demonstrate the presence of both single‐ and double‐
stranded forms in miR‐9 and double‐stranded form of miR‐124. It is 
remains enigmatic how miRNA is secreted by live neuronal cells not 
in complex with exosomes or microparticles. Our data suggest that 
the mitochondrial inhibitor NaN3 and protein transport inhibitor mo‐
nensin inhibited short‐term release but did not significantly affect 
long‐term cumulative release of miR‐9 and miR‐124, whereas ion‐
omycin induced calcium influx in neuronal cells and intensified this 
process. These data indicate that the secretion of miRNA depended 
on exocytosis, which in turn was stimulated by calcium signaling. 
Our data are in good agreement with previously published studies 
(Kuwabara, Hsieh, Nakashima, Taira, & Gage, 2004; Sohel, 2016; 
Zhang et al., 2015), showing the importance of all these processes 
for ECmiRNA release. We also found that production of miR‐124 and 
miR‐9 were substantially decreased by TTX. This finding implies that 
spontaneous electric activity of neurons was important for miRNA 
secretion. Electric activity of neurons is known to increase exocy‐
tosis (Chivet et al., 2012; Park, 2017), and also facilitate opening of 
voltage‐gated channel proteins that might also directly and/or indi‐
rectly contribute to the release of ECmiRNAs. This is quite an inter‐
esting and important finding, which will be further investigated in 
the future.
We found that ECmiRNA were protected from RNase. This indi‐
cates that miRNAs either exist in complexes with proteins or have a 
specialized conformation that is resistant to RNase. Previous studies 
also indicated that ECmiRNAs were RNase insensitive (Wang et al., 
2010). However, we also found that a large proportion of miRNAs 
were bound to the cell surface. Moreover, the cleavage of carbohy‐
drates from cell surfaces with β‐galactosidase enhanced the release 
of miR‐124 and miR‐9 into the extracellular space. We believe that 
binding of miRNA to cell surface glycolipids or glycoproteins may 
also contribute to their protection from RNase.
To exert intercellular communication, miRNAs have to bind to the 
surface of the recipient cell and be internalized into the cytoplasm. 
The internalization of miRNA occurs via multiple mechanisms. The 
first mechanism involves fusion of exosomes and microparticles with 
the plasma membrane. The second mechanism involves endocyto‐
sis of miRNA bound to the plasma membrane, and the third mech‐
anism implies uptake of miRNA:HDL complexes via the scavenger 
receptor SR‐BI. Our data demonstrate that the fraction >100 kDa 
was enriched with miRNA‐124 and miR‐9‐HDL complexes. This frac‐
tion >100 kDa resulted in upregulation of miR‐124 in macrophages. 
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F I G U R E  8   Influence of tetrodotoxin on the level of extracellular production of miR‐124 and miR‐9 by cultured cortical neurons. Primary 
mouse cortical neurons were cultured as described in Materials and Methods. The cells were untreated or pre‐treated with tetrodotoxin (TTX) 
for 24 hr, the media were changed to the fresh media with or without TTX at the 0‐min time point. The expression levels of miR‐124 (a) and 
miR‐9 (b) were assessed 1, 5, 15, 30, 60, and 120 min later by real‐time RT PCR as described in Materials and Methods. Cumulative values for 
miR‐124 and miR‐9 release were calculated as for Figure 7 and are shown in (c). In (a–c), mean ± SD of three separate experiments is shown 
on dotpolts (n = 3). In (c), **p < 0.01; unpaired Student’s t test) [Colour figure can be viewed at wileyonlinelibrary.com]
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Given that scavenger receptors SR‐BI are expressed in macrophages, 
microglia, and astrocytes (Husemann & Silverstein, 2001), we be‐
lieve that it is the main pathway of miR‐124 internalization in mi‐
croglia and astrocytes in vivo. Our in vitro experiments show that 
miRNA is co‐localized with GM1‐positive lipid rafts in the surface of 
macrophages and is also found in the cytoplasm. Therefore, there 
is also the possibility that the 10–100‐kDa fraction of NCM with 
miRNA‐124 could also bind to macrophage surfaces and become in‐
ternalized via endocytosis or phagocytosis.
The upregulation of miR‐124 in the cytoplasm of macrophages 
after addition of NCM could occur through two chief mechanisms: 
1) internalization of exogenous miR‐124 from the extracellular space 
and the cell surface into the cytoplasm, and 2) induction of endog‐
enous miR‐124 in macrophages. Indeed, very low levels of miR‐124 
were found in the nuclei of macrophages, indicating the possibil‐
ity of upregulation of miR‐124 on a transcriptional level. However, 
F I G U R E  9   Visualization of miR‐124 in macrophages in vitro 
and in microglia and astrocytes in vivo in mouse adult brain. Bone 
marrow‐derived macrophages (BMDMs) were incubated with 
medium (untreated) or in 50% brain slice conditioned medium 
(BSCM) for 4 hr as described in Materials and Methods. The cells 
were stained for cell plasma membrane marker GM1 with CTB‐
FITC (green) and nuclei with DAPI (blue) as described in Materials 
and Methods. MiR‐124 (red) was detected by fluorescence in situ 
hybridization as described in Materials and Methods. (a) Histology 
sections were prepared from the normal adult brain of perfused 
8‐ to 12‐week‐old B6 female mice as described in Materials and 
Methods. Microglia were stained with Iba1 (green; left image), 
and astroglia were stained with the anti‐GFAP antibody (green; 
right image). MiR‐124 (red) was detected by in situ hybridization 
as described in Materials and Methods. Open arrows indicated 
microglia and astrocytes without miR‐124 hybridization signal. 
Filled arrows indicate miR124‐positive microglia (left image) or 
astroglia (right image). Nuclei were stained with DAPI (blue). The bar 
is 10 μm 
F I G U R E  1 0   Model of horizontal transfer of miR‐124 and miR‐9 
from neurons to microglia. Electrically active neurons secrete 
exosomes with miR‐9, as well as miR‐124 with miR‐9 in naked 
form and/or in complex with low molecular weight proteins. 
Astrocytes secrete HDLs that bind to miR‐124 and miR‐9 in the 
extracellular space. Exosomes with miR‐9, miR‐124:HDL, and 
miR‐9:HDL complexes are taken up by microglia. MiR‐9 and 
miR‐124 are translocated to the cytoplasm of microglia via fusion 
of miR‐9‐positive exosomes with plasma membrane or transport 
of HDL‐miR‐124 and HDL‐miR‐9 into the cytoplasm via scavenger 
receptors. In the cytoplasm, miR‐124 (and possibly miR‐9) 
deactivate microglia, leading to downregulation of MHC class II and 
CD45. Inside the cell, miR‐124 are known to inhibit the CEBPα‐PU.1 
pathway, whereas miR‐9 inhibit NFκB. Both of these pathways are 
important for macrophage/microglia activation and expression of 
activation markers such as MHC class II and CD45 
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we could not detect expression of any of 3 transcripts for miR‐124 
precursors (pre‐miR‐124.1, pre‐miR‐124.2, and pre‐miR‐124.3) 
after co‐incubation with NCM or BSCM (not shown). At the same 
time, our previous study demonstrated that the expression of pre‐
miR‐124 transcripts was induced by IL‐4 and IL‐13 in macrophages 
(Veremeyko et al., 2013). However, when we used IL‐4‐ or IL‐4/13R‐
deficient animals, the level of expression of miR‐124 in microglia in 
vivo remained unaltered (Veremeyko et al., 2013). This result indi‐
cates that miR‐124 is probably translocated from neurons to glial 
cells including microglia and astrocytes rather than being induced 
on a transcriptional level. This impression is confirmed by the find‐
ing that pre‐miR‐124 transcripts were also not detected in ex‐vivo 
isolated microglia (not published). At the same time, we demon‐
strated here the localization of miR‐124 in Iba1‐positive microglia 
and GFAP‐positive astrocytes. Taken together, these findings favor 
our hypothesis of horizontal transfer of miR‐124 from neurons to 
glia.
Several studies suggest the importance of miRNA in deactivation 
of microglia and macrophages. We demonstrated that overexpres‐
sion of miR‐124 decreased M1 macrophage activation and promoted 
the M2 regulatory phenotype, whereas miR‐124 inhibitors increase 
the level of M1 activation (Ponomarev, Veremeyko, Barteneva 
et al., 2011; Veremeyko et al., 2013). We also found that miR‐124 
deactivated microglia in the normal CNS (Ponomarev, Veremeyko, 
Barteneva et al., 2011), whereas knockout of DICER (the enzyme 
responsible for processing of pre‐miRNA precursor molecules into 
the shorter form of functional miRNAs) resulted in elevated levels 
of activation of microglia in vivo (Varol et al., 2017). However, the 
absence of DICER in adult microglia did not result in a substantial 
level of spontaneous activation of these cells in the CNS in terms 
of upregulation of CD45 and MHC class II. Our study suggests that 
the role of microRNAs might be underestimated in DICER‐deficient 
mice, in that the expression of miRNA in microglia could also be in‐
duced by horizontal transfer of microRNAs from neurons. Thus, our 
study highlights the importance of neuron‐microglia communication 
in the maintenance of the deactivated phenotype of microglia in the 
normal CNS. Communications between neurons and microglia/as‐
trocytes were recently shown to be important for neuronal develop‐
ment and repair after injury, whereas signals from neuronal cells to 
microglia/astrocytes remain greatly understudied (Reemst, Noctor, 
Lucassen, & Hol, 2016; Szalay et al., 2016). We demonstrated the 
important role of miRNA‐124 and miR‐9 in this process, which would 
have applications for the development of future approaches to mod‐
ulate microglial cell activation during neuroinflammatory and neuro‐
degenerative diseases.
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